Ocular Therapeutix Inc. buy BiotechBee
Start price
07.09.22
/
60%
€5.70
Target price
31.12.24
€10.00
Performance (%)
43.52%
End price
14.12.24
€8.18
Summary
This prediction ended on 14.12.24 with a price of €8.18. With a performance of 43.52% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | 1.709% | 1.709% | 31.211% | 58.898% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
According to BiotechBee what are the pros and cons of Ocular Therapeutix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ocular Therapeutix Inc.
Buy beendet

